Brady Stephen R has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 550000 shares of Tempest Therapeutics, Inc. ($TPST) on January 02, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | Tempest Therapeutics, Inc. | $TPST | Brady Stephen R | President and CEO | A | Employee Stock Option (right to buy) | 550000 | $0.00 | 550,000.0000 | 0 | 9999.99% | 0.00% |
| July 3, 2024 | Tempest Therapeutics, Inc. | $TPST | Brady Stephen R | President and CEO | P | Common Stock | 35000 | $2.11 | 46,376.0000 | 0 | 307.67% | 0.00% |
| Jan. 3, 2024 | Tempest Therapeutics, Inc. | $TPST | Brady Stephen R | President and CEO | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2023 | Tempest Therapeutics, Inc. | $TPST | Brady Stephen R | President and CEO | A | Employee Stock Option (right to buy) | 725000 | $0.00 | 725,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Tempest Therapeutics, Inc. | $TPST | Brady Stephen R | Chief Executive Officer | A | Employee Stock Option (right to buy) | 177300 | $0.00 | 177,300.0000 | 0 | 9999.99% | 0.00% |